Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/23 07:35 | 11/17/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Manning Paul B | VA | T | 2 | P | 14,983 | 0.9044 | 0 | 16,567 | 238 | 23,518 | I | |||||||||||||||
8/16/23 20:53 | 8/16/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Stalfort John A III | TX | D | 1 | P | 700 | 0.9000 | 0 | 778 | 67 | 1,934 | M | |||||||||||||||
8/16/23 20:52 | 8/16/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Nolan Sean P. | TX | DO | CEO | 1 | P | 400 | 0.9000 | 0 | 444 | 41 | 1,537 | I | ||||||||||||||
8/16/23 20:51 | 8/16/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Donenberg Phillip B. | TX | D | 1 | P | 100 | 0.9000 | 0 | 111 | 999% | 114 | D | |||||||||||||||
5/18/23 16:44 | 5/16/23 | TSHA | Health | BioPrd | Biological Products, (No Diag | Nagendran Sukumar | TX | DO | P,Head o | 1 | P | 3 | 0.6800 | 0 | 5 | 17 | 34 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |